89R22703 MCF-F
 
  By: Ordaz, Orr, Rose, Frank, Howard, et al. H.B. No. 220
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the care provided to sexual assault survivors by health
  care facilities.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 323.004, Health and Safety Code, is
  amended by amending Subsection (b) and adding Subsection (b-2) to
  read as follows:
         (b)  A health care facility providing care to a sexual
  assault survivor shall provide the survivor with:
               (1)  subject to Subsection (b-1), a forensic medical
  examination in accordance with Subchapter B, Chapter 420,
  Government Code, and Subchapter G, Chapter 56A, Code of Criminal
  Procedure;
               (2)  a private area, if available, to wait or speak with
  the appropriate medical, legal, or sexual assault crisis center
  staff or volunteer until a physician, nurse, or physician assistant
  is able to treat the survivor;
               (3)  access to a sexual assault program advocate, if
  available, as provided by Subchapter H, Chapter 56A, Code of
  Criminal Procedure;
               (4)  the information form required by Section 323.005;
               (5)  a private treatment room, if available;
               (6)  if indicated by the history of contact, access to
  appropriate prophylaxis for exposure to sexually transmitted
  infections;
               (7)  the name and telephone number of the nearest
  sexual assault crisis center; [and]
               (8)  if the health care facility has shower facilities,
  access to a shower at no cost to the survivor after the examination
  described by Subdivision (1); and
               (9)  if the survivor consents and the treatment is
  clinically indicated, an emergency contraceptive approved by the
  United States Food and Drug Administration to prevent pregnancy by
  delaying ovulation.
         (b-2)  A health care facility providing care to a sexual
  assault survivor may not provide or offer to provide the survivor
  with a drug or device that terminates a pregnancy.
         SECTION 2.  This Act takes effect September 1, 2025.